A phase 3 head-to-head trial comparing the effectiveness of Kyprolis (carfilzomib) in combination with dexamethasone has shown better outcomes in patients with multiple myeloma than the current standard of care,...
A phase 3 head-to-head trial comparing the effectiveness of Kyprolis (carfilzomib) in combination with dexamethasone has shown better outcomes in patients with multiple myeloma than the current standard of care,...
A...